Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses

Clinical and Experimental Immunology

Volumn 174, Issue 1, 2013, Pages 45-52

  Rieber, N ^a   Gille, C ^a   Kostlin N ^a   Schafer I ^a   Spring, B ^a   Ost, M ^a   Spieles, H ^a   Kugel, H A ^a   Pfeiffer, M ^a   Heininger, V ^a   Alkhaled, M ^a   Hector, A ^a   Mays, L ^a   Kormann, M ^a   Zundel, S ^a   Fuchs, J ^a   Handgretinger, R ^a   Poets, C F ^a   Hartl, D ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cord blood; Gr MDSC; MDSC; Myeloid derived suppressor cells; Neonatal; Neutrophilic; NK cells; Th17

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; BLOOD; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INNATE IMMUNITY; NATURAL KILLER CELL; NEUTROPHIL; NEWBORN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; UMBILICAL CORD BLOOD;

CORD BLOOD; GR-MDSC; MDSC; MYELOID-DERIVED SUPPRESSOR CELLS; NEONATAL; NEUTROPHILIC; NK CELLS; TH17;

ADAPTIVE IMMUNITY; ADULT; CD8-POSITIVE T-LYMPHOCYTES; FETAL BLOOD; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; INFANT; INFANT, NEWBORN; MYELOID CELLS; NEUTROPHILS;

EID: 84883643725     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12143     Document Type: Article

References (42)

1. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7:379-390.
2. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4:553-564.
3. Gille C, Spring B, Tewes LJ etal. Diminished response to interleukin-10 and reduced antibody-dependent cellular cytotoxicity of cord blood monocyte-derived macrophages. Pediatr Res 2006; 60:152-157.
4. Marchant A, Goldman M. T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 2005; 141:10-18.
5. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 2006; 118:137-144.
6. Zaghouani H, Hoeman CM, Adkins B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol 2009; 30:585-591.
7. Fernandez MA, Evans IA, Hassan EH, Carbone FR, Jones CA. Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo. Eur J Immunol 2008; 38:102-113.
8. Fritzsching B, Oberle N, Pauly E etal. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 2006; 108:3371-3378.
9. Hunt DW, Huppertz HI, Jiang HJ, Petty RE. Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood 1994; 84:4333-4343.
10. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-174.
11. Peranzoni E, Zilio S, Marigo I etal. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol 2010; 22:238-244.
12. Brandau S, Trellakis S, Bruderek K etal. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 2011; 89:311-317.
13. Lechner MG, Liebertz DJ, Epstein AL. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 2010; 185:2273-2284.
14. Rodriguez PC, Ernstoff MS, Hernandez C etal. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 2009; 69:1553-1560.
15. Chen S, Akbar SM, Abe M, Hiasa Y, Onji M. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol 2011; 166:134-142.
16. Rieber N, Brand A, Hector A etal. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol 2013; 190:1276-1284.
17. Elkabets M, Ribeiro VS, Dinarello CA etal. IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. Eur J Immunol 2010; 40:3347-3357.
18. Poschke I, Mougiakakos D, Hansson J, Masucci GV, Kiessling R. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res 2010; 70:4335-4345.
19. Li H, Han Y, Guo Q, Zhang M, Cao X. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 2009; 182:240-249.
20. Lang P, Barbin K, Feuchtinger T etal. Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts. Blood 2004; 103:3982-3985.
21. Ioannou M, Alissafi T, Lazaridis I etal. Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. J Immunol 2012; 188:1136-1146.
22. Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011; 117:6532-6541.
23. Sundstrom Y, Nilsson C, Lilja G, Karre K, Troye-Blomberg M, Berg L. The expression of human natural killer cell receptors in early life. Scand J Immunol 2007; 66:335-344.
24. Dalle JH, Menezes J, Wagner E etal. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res 2005; 57:649-655.
25. Luevano M, Daryouzeh M, Alnabhan R etal. The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. Hum Immunol 2012; 73:248-257.
26. Peoples JD, Cheung S, Nesin M etal. Neonatal cord blood subsets and cytokine response to bacterial antigens. Am J Perinatol 2009; 26:647-657.
27. Perez A, Gurbindo MD, Resino S, Aguaron A, Munoz-Fernandez MA. NK cell increase in neonates from the preterm to the full-term period of gestation. Neonatology 2007; 92:158-163.
28. Fortin C, Huang X, Yang Y. NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells. J Immunol 2012; 189:1843-1849.
29. Berrington JE, Barge D, Fenton AC, Cant AJ, Spickett GP. Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analysed by single platform flow cytometry. Clin Exp Immunol 2005; 140:289-292.
30. Juretic E, Juretic A, Uzarevic B, Petrovecki M. Alterations in lymphocyte phenotype of infected preterm newborns. Biol Neonate 2001; 80:223-227.
31. Gasparoni A, Ciardelli L, Avanzini A etal. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol Neonate 2003; 84:297-303.
32. Leibson PJ, Hunter-Laszlo M, Douvas GS, Hayward AR. Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines. J Clin Immunol 1986; 6:216-224.
33. Schlecker E, Stojanovic A, Eisen C etal. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J Immunol 2012; 189:5602-5611.
34. Brown JA, Boussiotis VA. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008; 127:286-297.
35. Highfill SL, Rodriguez PC, Zhou Q etal. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010; 116:5738-5747.
36. Kim Y-J, Broxmeyer HE. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol 2011; 79:112-126.
37. Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol 2011; 32:19-25.
38. Luyckx A, Schouppe E, Rutgeerts O etal. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin Immunol 2012; 143:83-87.
39. Cheng P, Corzo CA, Luetteke N etal. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008; 205:2235-2249.
40. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011; 60:1419-1430.
41. Gaddy J, Broxmeyer HE. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol 1997; 180:132-142.
42. Movahedi K, Guilliams M, Van den Bossche J etal. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008; 111:4233-4244.